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Abstract
Background/Aim. According to the current principles,
autonomous functional thyroid nodules are treated by sur-
gery or by radioiodin therapy. Ultrasound guided percuta-
neous ethanol injection into solid tumors of the soft tissues
was a starting point in attempts to treat the thyroid nodules
by the same method. The aim of the study was to assess the
efficiency of percutaneous injection in treating solitary,
nontoxic, autonomous thyroid nodules of up to 15 mL vol-
ume.  Methods. In 25 patients with solitary nontoxic
autonomous thyroid nodules diagnosed by tehnetium-99m
scanning as an intensive area having a complete supremacy
in the paranodal tissue, an ultrasound guided percutaneous
ethanol injection was applied. The procedure was carried
out repeatedly once a week until the reduction in nodule
size to 50% of the initial size was achieved. Results. An av-
erage size of the nodule before curing was 9.68 ± 5.01 mL.
An average quantity of the injected ethanol was 9.52 ± 5.08
mL, ie 1.06 ± 0.48 mL/mg of the tissue. The regression of
the nodule size in the successfully (Δvol% u = -
57.09 ± 13.75%,  p  <  0.001) and partly successfully cured
(Δvol du = -48.45 ± 14.35%, p < 0.05) was statistically sig-
nificant compared to the size before the treatment. After
ceasing ethanol injection, 18 months later, a further size re-
gression (Δvol% = -79.20 ± 9.89%) compared to the initial
one (p < 0.001) was noticed. Soon, after the procedure was
finished, a statistically significant concentration increase of
Thyroid Stimulating Hormone (TSH) was noticed com-
pared to the initial values (0.18 ± 0.16 vs 0.34 ± 0.31 mU/L,
p < 0.01). According to the given criteria, in two female pa-
tients satisfactory results were not achieved, but, a year later,
in one of them the nodule was not seen by repeated scinti-
gram. The number and frequency of side effects were insig-
nificant. Conclusion. Repeated percutaneous ethanol injec-
tions into nontoxic solitary autonomous thyroid nodules re-
sult in disappearing of authonomy. The regression of the
nodule size of more than 50% compared to its initial vol-
ume, as well as the increase in concentration of TSH for
more than 50% are the signs of a successful treatment.
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Apstrakt
Uvod/Cilj. Prema sadašnjim principima, autonomni fun-
kcionalni tiroidni nodusi leče se operativno ili terapijskom
primenom radioaktivnog joda. Perkutana, ultrazvučno
vođena aplikacija etanola u solidne tumore mekih tkiva
bila je polazna osnova za pokušaje lečenja tiroidnih nodu-
sa istom metodom. Cilj ovog rada bio je da se ocene tera-
pijski efekti perkutane aplikacije etanola kod solitarnih,
netoksičnih autonomnih tiroidnih nodusa zapremine do
15 mL. Metode. Kod 25 bolesnika sa solitarnim netoksi-
čnim nodusima koji se scintigrafski (tehnecijum 99m) in-
tenzivnije prikazuju i potpuno suprimiraju paranodalno
tkivo, uz pomoć ultrazvuka perkutano je aplikovan etanol.
Procedura je ponavljana u sedmičnim intervalima dok nije
ostvarena redukcija veličine nodusa od 50% u odnosu na
početnu vrednost. Rezultati. Prosečna veličina nodusa
pre lečenja iznosila je 9,68 ± 5,01 mL. Prosečna količina
aplikovanog etanola iznosila je 9,52 ± 5,08 mL, odnosno
1,06 ± 0,48 mL/mg tkiva. Regresija veličine nodusa kod
uspešno (∆vol% u = -57,09 ± 13,75%, p < 0,001) i deli-
mično uspešno lečenih (∆vol du = -48,45 ± 14,35%,
p < 0,05) bila je statistički značajna u odnosu na veličinu
pre lečenja. Po prestanku aplikacija etanola, nakon 18 me-
seci uočena je dalja regresija veličine nodusa (∆vol% = -
79,20 ± 9,89%) u odnosu na početnu (p < 0,001). Nepos-
redno nakon završene procedure registrovan je statistički
značajan porast koncentracije tireostimulirajućeg hormo-Strana 768 VOJNOSANITETSKI PREGLED Volumen 68, Broj 9
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na (TSH) u odnosu na početne vrednosti (0,18 ± 0,16 vs
0,34 ± 0,31 mU/L, p < 0,01). Prema zadatim kriterijumi-
ma kod dve bolesnice nisu ostvareni zadovoljavajući efe-
kti lečenja, s tim što se kod jedne, nakon godinu dana, na
ponovljenom scintigramu nodus više nije prikazivao. Broj
i učestalost neželjenih efekata bio je zanemarljivo mali.
Zaključak. Ponavljane perkutane aplikacije etanola u
netoksične solitarne autonomne noduse štitaste žlezde do-
vode do isčezavanja autonomije. Regresija veličine nodusa
za više od 50% u odnosu na početni volumen, kao i po-
rast koncentracije TSH za više od 50%, pokazatelji su us-
pešnog ishoda lečenja.
Ključne reči:
tireoidna žlezda, bolesti; tireoidna žlezda, hormoni;
gušavost; etanol; ultrazvuk.
Introduction
Solitary autonomous functional thyroid nodules
(AFTN) are parts of thyroid parenchymas which in func-
tional and in the sense of controlling growth act separately
from the regulatory action of hypophysis, ie thyroid stimu-
lating hormone (TSH). Laboratory criterion for diagnosing is
an inability to suppress the function of nodules by suppres-
sive doses of thyroid hormones. At the same time, the sup-
pressed paranodal tissue has retained the ability to answer
the stimulation by exogenous giving TSH. Unlike toxic ones,
nontoxic nodules have normal serum levels of thyroid hor-
mones.
According to the current principles, toxic nodules are
treated surgically or with therapeutic application of radioac-
tive (RA) iodine. The need for curing the nontoxic AFTNs is
based on the observation that most of the ill have subnormal
TSH levels and, hence, subclinical hyperthyreosis. On the
other hand, taking larger quantities of iodine, which occurs
when giving iodine contrast media, the drugs containing io-
dine, or when eating food rich in iodine, multiplies the possi-
bility of evolution of nontoxic nodules into the toxic ones.
The results achieved by the use of ethanol in treatement
of hepatocellular carcinomas 
2 and benign cysts in the thy-
roid gland
 3 were a starting point for the attempts to cure the
autonomous nodules by the same method. The procedure of
percutaneous ethanol injection (PAE) into the nodules of thy-
roid gland was promoted at the beginning of the 1990s.
Then, there were the first results published of treating eight
patients in this way in whom the regression in nodules size
and the disappearance of autonomy
 4 were achieved, regard-
less a small number of ethanol injections. Later observations
of a few tenths to over a hundred patients who were followed
during long intervals (4–8.5 years) proved good effects of
curing. In the largest number of the cured, PAE led to a
complete or a partial curing, with a very small number of re-
cidives. In a certain number of patients (about 12%), mainly
with toxic nodules, there were no results of curing
 5–7.
In an attempt to contribute to the achievements which
would make this method generally accepted we started with
the fact that there was not a single study with a selection of
patients regarding the autonomy level, as well as that most
studies included heterogeneous groups of patients with
nodal, polynodal, most often toxic nodules of various sizes.
The aim of this study was to estimate therapeutical ef-
fects of 15 mL percutaneous ethanol injection in patients
with nontoxic, solitary AFTNs, which most often occur in
clinical practice.
Methods
The study included 25 patients with solitary nodules
which appeared more intense on scintigraphy (Te-99m) and
had a complete supremacy in paranodal tissue. According to
serum concentration of thyroid hormones and TSH, the pa-
tients with toxic nodules were excluded. By cytological
analysis of aspirates from nodules any doubts of malignancy
were eliminated.
A Hewlett Pacard apparatus with a linear probe of 7.5
MHz was used for echotomographic estimation and control-
ling the injection. The volume of nodules was calculated ac-
cording to the formula for ovoid: V = π/6 × A x B × C (A –
craniocaudal, B – anteroposterior, C – mediolateral nodule
diameter) and it was expressed in millilitres, ie milligrams of
tissue. The amount of the injected ethanol per seance was not
determined in advance, but ethanol was injected up to the
point of perfusion and not more than 2/3 of the visible sur-
face of the nodule. Color Doppler was used to direct the in-
jection into the areas with the largest number of exposed
capillaries. The quantity of ethanol determined in this way
was expressed in mL of ethanol/mL (mg) of the nodule tis-
sue. The injections were done in the outpatient department,
repeatedly, at intervals of once a week.
With the aim to estimate the effects, control scintigra-
phy was carried out on condition that the following three
criteria were fulfilled: regression of nodule volume to at least
50% compared to the initial one; significantly changed
echotomographic structure of the nodule with the earlier hy-
poechographic fields disappearing; when not a single ex-
posed capillary within the nodule could be seen on colour
Doppler.
The effects of treatment were defined as: successful (s),
partly successful (ps), and unsuccessful (u), the scintigraphic
finding being a determiner. Criteria for estimating success of
treatment were: disappearance of all clinical manifestations of
the illness; increase in concentration of TSH for at least 50%
compared to its level before treatment; decrease in nodule vol-
ume for 50% compared to the initial one; scintigraphic finding
on which the earlier suppressed paranodal tissue is completely
shown (Figure 1 a, b). Partly successful: the patients with three
of the four formerly mentioned criteria fulfilled. Unsuccessful:
only two of the four mentioned criteria fulfilled.
All immediate side effects were noticed, as well as their
persistence. The examination was carried out according to
the principle of prospective clinical study. All the patients
were introduced to the procedure and the aim of treatment,
and only those who agreed to be treated on this way were in-Volumen 68, Broj 9 VOJNOSANITETSKI PREGLED Strana 769
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cluded in the study. The criterion for excluding the patients
was their own decision.
All the results in tables were shown as an average value
± standard deviation (ґ ± SD). Depending on the distribution
of features, statistical importance among the groups was es-
timated by the Student’s t-test or by the Mann-Whitney U-
test. Comparison of the frequencies, depending on their lo-
cation, was made by using χ
2-test or by Kolmorogov-
Smirnov test. Connection with various features was tested by
using the Pearson’s correlation quotient. A statistically singi-
ficant difference in the groups was defined on the three lev-
els of possibilities: p < 0.05; p < 0.01 and p < 0.001.
Results
The procedure was applied on 25 patients (23 women
and 2 men), 19–76 (47.18 ± 16.3) years of age. An average
nodule volume before treatment was 9.68 ± 5.01 mL. As for
echo structure, 64% (16/25) of those being cured had a
clearly parenchymatous structure, while 36% (9/25) had
nodules with the signs of cystic degeneration. Regardless
echo structure, all the nodules showed diffusionally accentu-
ated vascularisation.
An average quantity of the injected ethanol was
9.52 ± 5.08 mL ie 1.06 ± 0.48 mL/mg of tissue. Injection rate
was 4 to 12 applications.
The regression of nodules was expressed in percents of
nodules diminishing at the end of treatment compared to
their initial volume (Δvol %). In all the patients, a statisti-
cally significant diminishing of nodules volume was
achieved, being slightly larger nodules with the signs of cys-
tic degeneration (Table 1).
As for the results, the successfully (Δvol% s  = -
57.09 ± 13.75%,  p  <  0.001) and partly successfully cured
(Δvol ps = 48.45 ± 14.35%. p < 0.05) showed a statistically
singificant difference in diminishing as compared to nodules
volume before the treatment. Although the successfully
cured, compared to the partly successfully cured ones,
showed a higher level of volume diminishing, this difference
was not statistically singificant. However, if nodules vol-
umes were expressed in milliliters, we would find a higher
level of nodule size regression in the successfully cured than
in the partly successfully cured ones. This difference is sta-
tistically singificant (s = 3.17 ± 1.24 vs ps = 3.17 ± 1.24 mL
p < 0.01) (Table 2; Figures 2a, b and 3 a, b and c).
After stopping ethanol injection, all the patients were
followed during the next 18 months. Control examinations
were done every 6 months. Nodules volume reduction after
18 months was Δvol% = -79.20 ± 9.89% as compared to the
initial one (p < 0.001) (Table 3).
The function of the thyroid gland was estimated by
measuring the levels of thyroid hormones: triodothyronine
(T3), tyroxine (T4), TSH and tyreoglobulin (Tg). The values
were controlled before, immediately after finishing the pro-
cedure and after 6, 12, and 18 months following finishing the
injection (Table 4, Figure 4).
 a)  b)
Fig. 1 – Scintigraphic findings: a) appearance before and b) afther the successful treatment
 with percutaneous ethanol injection
Table 1
Nodules volume before and after percutaneous ethanol injection in realtion to echo structure
Nodules volume, ґ  SD (mL) ECHO structure Before  p  After vol (%), before/after
 Parenchymatous 7.90  3.31 0.001 3.78  1.99 -52.08  13.69
Cyst.degener. 12.84  6.11 0.01 5.57  3.47 -55.26  16.36
p  < 0.05 ns ns
ns – non significant
Table 2
Nodules volume before and after percutaneous ethanol injection in relation to outcomes of the treatment
Nodules volume, ґ  SD (mL) Treatment outcome Before  p  After vol (%), before/after
Successfull 7.91  3.68 0.001 3.17  1.24 -57.09  13.75
Partly successfull 12.70  6.39 0.05 6.20  3.11 -48.45  14.35
pn s  < 0.01 ns
ns – non significantStrana 770 VOJNOSANITETSKI PREGLED Volumen 68, Broj 9
Andjelković Z, et al. Vojnosanit Pregl 2011; 68(9): 767–773.
 a)  b)
Fig. 2 – Echotomographic appearance of AFTN: a) before and b) after successful treatment with percutaneous ethanol
injection
 a)  b)  c)
Fig. 3 – Scintigraphic appearance of a nodule in the left lobe of the thyroid before, immediatly after percutaneous
ethanol injection (a and b) and one year later (c)
Table 3
Nodules volume (%) at the begining and vol(%) during 18 month period
Time period (month) Nodules volume (mL) vol (%)
0 9.68  5.01 –
6 3.55  2.44
‡ 63.00  13.36
12 3.19  2.21
† 70.70  12.08
18 2.51  2.51* 79.20  9.89
*p < 0.05; 
†p < 0.01; 
‡p < 0.001 in relation to the value at the begining (0)
Table 4
Function of the thyroid gland during 18 month period
Thyroid hormones levels Time period
T3 (nmoL/L) T4 (nmoL/L) TSH (IJ/L) Tg (g/L)
Before 2.84  0.97 156.32  54.68 0.18  0.16 62.84  39.13
After 2.33  0.49* 140.92  31.52 0.34  0.31
† 108.32  44.70
‡
6 months  1.87  0.40
‡ 124.21  14.96
† 0.69  0.40
‡ 38.49  26.70
†
12 months 1.97  0.28
† 128.17  12.97 0.77  0.44
† 33.50  16.18
†
18 months 1.90  0.38* 126.62  15.26 1.12  0.39* 25.95  23.53*
*p < 0.05; 
†p < 0.01; 
‡p < 0.001 in relation to levels at the begining
Normal levels: T3 = 1.2 - 2.8; T4 = 60 – 160; TSH = 0 – 4; Tg = up to 50
Effects of treatement
Days between two applications
4
8
12
16
20
24
28
32
s ps(u)
Mean valuae
Mean valuae
p < 0.01
s -  successfully
ps(u) – partly succ. and unsuccessfully-
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Discussion
Autonomous thyroid nodules represent 5%–10% of all
palpable or in other ways recognisible thyroid nodules. There
are a few phases in the development of AFTN. First, there
appears a functional nodule without an autonomy. In its fur-
ther evolution it can grow into an autonomus hyperfunctional
or toxic tyroid nodule. In the controlled, prospective clinical
studies it is shown that after a 5-year follow up, 15%–20% of
the autonomous nodules larger than 3 cm become toxic
 8, 9,
and that they are treated with either surgery or therapeutical
application of RA iodine. In treatment nontoxic AFTN is still
a subject of discussion, with a number of objections. The op-
posite attitudes are problematic promoting either clinical
following or surgical treatment. Those who are for clinical
following base their attitude on the fact that only a small
number of AFTNs evoluate into the toxic ones, as well as
that the possibility of malignancy is slight
 10, 11.
During the last 20 years or so, ultrasound guided percu-
taneous ethanol injection has become a successful way of
curing both malignat and benign soft tissue tumors. The prin-
ciple of treatment is based on the knowledge that after inject-
ing ethanol regularly spreads within the tumor lesion by diffu-
sion and, then, it causes an inactivity of the oxidative enzymes,
dehydration of the cells, denaturation of proteins, venous mi-
crothrombosis and coagulation necrosis followed by fibrosis
 12.
The surrounding tissue is saved since it appears that ethanol
stays within the tumor lesion. The first reports of positive ef-
fects refer to local ethanol injection into hepatocellular carci-
nomas derived from cirrhosis of the liver
 2. Inactivation of
parathyroid adenomas by ethanol appeared to be successful in
an important number of those having primary hyperparathyro-
ism and, in some cases, after an unsuccessful surgical explora-
tion, it can be the only possible choice of treatment
 13, 14. Scle-
rosing of benign cystic nodules in the thyroid gland has been
used for a long time, and there are more and more proofs of
reduction in its size and therapeutical efficiency of PAE in the
treatement of benign solid nodules
 15.
Percutaneous ethanol injection was introduced into
clinical practice by Livraghi et al. 
16 in 1990. It was shown
then that regression in nodule size, followed by disappear-
ance of autonomy, was achieved, despite a small number of
ethanol injections. Later examinations of a larger number of
patients who were followed over longer time intervals
proved positive effects of this way of curing with only a
slight number of complications
 5–7. It was also shown that
subclinical hyperthyreosis was corrected in all, while the
manifested one was cured in 52%–80% of patients, with only
a slight number of recidives. The achieved nodule size re-
gression was from 21% to 88% compared to the initial size.
In our group of patients there were 16 (64%) success-
fully treated, 7 (28%) partly successfully treated, while in 2
(8%) patients the treatment had no effect. Despite the fact
that the criteria for estimation success in the results were
very strict, looking for the reasons for such results we started
with the question whether nodule volume had an effect on
the results of treatment. The attitudes concerning the con-
nection between nodule size and the results of treatment, ac-
cording to the current knowledge, are not completely unique.
There prevails an attitude that nodule size only partly affects
the results of treatment. Best results were achieved in non-
toxic AFTN the volume of which was not bigger than 10–13
mL
 16–18. Average nodule volume in our patients was
9.68  ±  5.01 mL where the cystic degenerated nodules had
quite a bigger volume compared to the parenchymatous ones.
Regarding the results, the nodules which were partly cured
and unsuccessfully cured were bigger in comparison with the
successfully cured ones. This difference, however, was not
statistically singificant (Vol ps + u > Vol s; ns). The cited re-
sults led to a conclusion that the nodules of smaller volumes
could be cured more easily. However, by linear regressive
analysis the correlation between the nodule volume and the
results of treated was not proved. It was shown that the de-
gree of nodule vascularisation had far greater importance for
a successful curing. It was noticed that during the treatment,
at the time of the planned ultrasound controls, the shape of
vascularisation changed in that way that the blood flow
gradually weakened, first within parenchyma, and later
around the edge of the nodule. At the end of the procedure,
in the successfully cured, both types of vascularisation com-
pletely disappeared. Together with the lower blood flow we
noticed a regression in nodule size and appearance of fibrosis
in parenchyma. The explanation for this could lie in the no-
ticed occurence that the well vascularised nodules made pos-
sible a quicker and a more regular distribution of the injected
ethanol, so that even the small amounts of the injected etha-
nol  reached evenly all the parts of nodules and caused the
tissue degradation.
Reduction in nodules size was expressed in percents at
the end of treatment compared to their initial volume
(Δvol%). We first noticed the good effects of ethanol inject-
ing by the signs of reducting in nodules volume, and we also
took into consideration the personal sensation of the patients
at control examinations. Size regression represents the oc-
curence about which there is the smallest number of dis-
agreements in the literature. There is a generally accepted at-
titude that the direct effect of ethanol is first to be recognised
according to the nodules size reduction which, depending on
the duration of the follow-up, was from 20%
 19 even up to
81%–93%
 20, 21 compared to their initial size. Does Δvol%
have an effect on the results of treatment? Similar to some
other authors
 20, by following our patients we noticed that
nodules with the positive results of curing had a bigger
Δvol% in comparison with the nodules with the partly suc-
cessful and unsuccessful results of treatment. We started
with the supposition that if a greater size reduction was
achieved during therapy there was a greater possibility of
getting positive results of curing. We checked our supposi-
tion by linear regressive analysis and proved a linear corre-
lation between the degree of regression and the nodule size
and, hence, the success of curing (r = -0.2594, p < 0.05). De-
spite the proved linear correlation between the degree of re-
gression and nodule size and the success of curing, compari-
sons within the group offered us some interesting ideas and
conclusions. Out of 25 patients, 16 (64%) were successfully
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were unsuccessfully cured. After comparing Δvol% of the
successfully cured with the partly successfully and unsuc-
cessfully cured there was found no statistically singificant
difference. Looking for the reasons of curing to be successful
in some patients, but partly successful or unsuccessful in
other we analysed some characteristics of nodules and the
curing procedures. Nodules in the subgroup of the success-
fully treated were of smaller dimensions compared to the un-
successfully treated but this difference was not statistically
singificant. So, we could not accept nodules size as a reason
for the unsuccessful results of curing. Both subgroups did not
differ in ultrasound structure of the nodules, the ways of vas-
cularisation, the quantity of the injected ethanol and the
number of injections. A statistically singificant difference
was noticed in only the time intervals between the two injec-
tions. In the successfully cured, a period between the two
injections was 12.7 days on average, and in the partly suc-
cessfully treated and unsuccessfully treated 7.43 days
(p < 0.01). The difference in a period between the two etha-
nol injections was made on purpose as the result of the first
experiences during the introduction of the procedure into
practical work. Namely, very early it was noticed that the
nodule size regression continued even after ceasing ethanol
injection. It appeared that a year following ceasing ethanol
injection nodules regressed another 16% in comparison with
their volume at the end of curing. We supposed that for the
occurence of a number of involutive changes, from cyto-
chemical to fibrosal ones, a certain period of time was neces-
sary. Having that in mind, there is a small possibility that a
larger quantity of the injected ethanol would fasten, or that a
smaller quantity would slow down this process which has its
logical sequence, from functional to definite morphological
changes. We supposed that the newly injected quantity of
ethanol only perpetuated the process of degradation and con-
tinued progression towards final necrosis and replacement by a
fibrotic tissue. Considering the first noticing in mind and
thinking in this way, we controlled all the patients weekly, but
we adjusted ethanol injection individually to a period from 2 to
3 weeks, giving chance to the previously injected ethanol to do
its function of destruction. We followed our patients 18
months after finishing the treatment. Despite stopping ethanol
injections, further regression in size was noticed, which proved
the cited suppositions and conclusions.
In the patient with the results of curing initially defined
as unsuccessful, with already described clinical findings, af-
ter a year, during repeated scintigraphy, the nodule was not
visible any more. We suppose that quite probably, after a pe-
riod of time, in all the patients who were partially treated (as
they were classified at the end of ethanol injection), the re-
sults of scintigraphy approved the disappearance of the
autonomy.
By observing the thyroid gland function, an increase in
TSH was noticed as a sign of autonomy disappearance, and
as the proof of a successful treatment. The values of Tg im-
mediately after the end of curing showed an increase in value
which we considered was due to degeneration in nodule tis-
sue. In the later course, with the development of fibrosis and
regression of the size, Tg values lowered, too.
Carrying out PAE is primarily based on the skill and
experience of the doctor who applies the procedure which, to
some extent, causes the appearance and content of side ef-
fects. Some of them, such as pain, overflowing of the thyroid
hormones into circulation, and the development of thyroid
antigen are justifiably present and are the consequence of a
direct contact of ethanol with the nodule tissue. In our series
of patients, the side effects of the procedure were milder and
did not disturb further carrying out or possible ceasing of
therapy. The degree of discomforts that appeared and the
definition of the efficiency of treatment were estimated on
the basis of the questionnaire which was filled in by the pa-
tients at the end of therapy, and their intensity was ranged by
the index from 1 to 5. In 91.3% of the treated patients there
was pain and burning at the site of injection of an average
intensity of 2.7 index points. In nearly one half of the treated
(43.47% to 52.17%) pain spreaded to the jaw, shoulder, chest
and ear, and it was marked with the index from 1.08 to 1.26.
The appearance of local and/or projected pain, as it can be
seen, represents an inevitable manifestation of the procedure.
Luckily, these manifestations which can, to some extent,
complicate the procedure, had a very weak intensity. Nearly
10% of the treated did not feel pain, or, what was more
likely, they did not consider it an important side effect. It
seems that the intensity of pain and its eventual further
spreading mostly depend on the location of the nodule, its
ultrasound structure and its vicinity to the thyroid capsule.
Pain was less severe in cystically degenerated nodules com-
pared to the ones with parenchymal structure, but it became
more intense as the number of injections grew and with the
appearance of sclerosis within the nodule. Then, it was prac-
tically impossible to prevent overflowing of even small
quantities of ethanol extranodally. Thyroid capsule seems to
be the best innerved part of the thyroid since curing nodules
in its vicinity was most painful, and pain always spreaded
away, most often as far as the temporomandibular joint and
ear. In nodules localized quite near the lower pole of the thy-
roid lobe propagation of pain went along the middle chest or
into shoulder. The mentioned discomforts were temporary
and mainly lasted short. Thus, in 86.9% of the treated the
discomforts were present for only a few hours after injection
while in 13.1% of patients they prolonged until the next day.
A slight number of patients reported having difficulty with
moving their neck, an occiput headache and a temporary
sense of slackening of vigour, as described by other authors.
Conclusion
It can be concluded that repeated percutaneous ethanol
injections into nontoxic solitary autonomous thyroid nod-
ules lead to autonomy disappearance. Regression in nodule
size for more than 50% as compared to the initial one, as
well as the growth of concentration of TSH for more than
50% are the signs of success in therapy. Nodule size does
not affect either the result of curing or the quantity of the
injected ethanol. Side effects of the procedure are rare and
directly depend on the experience of the doctor carrying out
the procedure.Volumen 68, Broj 9 VOJNOSANITETSKI PREGLED Strana 773
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